![](https://isrreports.com/wp-content/uploads/2012/07/ISR-Reports-Primer-Biosimilars-in-the-US-Oncology-Market-Report-Preview-1.jpg)
Primer: Biosimilars in the US Oncology Market
$880.00 – $1,760.00
Related products
-
Biologic API Contract Manufacturer Quality Benchmarking (2016)
$4,960.00 – $9,920.00 -
Biosimilar Primer: US Physicians’ Attitudes, Beliefs, and Intentions
$850.00 – $1,700.00 -
Biologic API Contract Manufacturer Quality Benchmarking (2nd edition)
$5,400.00 – $10,800.00 -
Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices
$750.00 – $1,500.00